Jump to content

Possible Lobectomy after radiation?


Minh

Recommended Posts

Good morning Lexie and Tom,

Here is my latest update. In the past couple of weeks, I went for second opinion with a local community group of medical oncologist and radiation oncologist. And the new oncologist told me I could be staged at stage 1a2 or stage 4 depends on if one or both nodules and pleural effusion confirmed positive for cancer.  Meanwhile, he ordered a liquid biopsy (Guardant 360) and the result as shown below. The test result was sent to me, but I still have to make appointment to see new oncologist to discuss what it means. Next week, I will go back to MD Anderson for biopsy of the second nodule 2.6cm in the lingula.

I called and ask questions but since I am still in diagnostic phase, they can not make any comments until all tests are completed. With all the up to date test results I have posted here, am I going down the right path? Am I missing anything that I should have done (additional tests, 2nd opinion, new specialists, etc...)? What is the Guardant 360 result means? I am anxious to find out. I have made appointment to see oncologist, but I won't be able to see him until Nov 8th. What else/more would you do if you are in my situation? Please help make suggestions.

Guardant 360.JPG

Link to comment
Share on other sites

Minh,

I am sorry, I don't know much about interpreting the Guardant 360 test so I can't offer an answer.

But, you decision for a second opinion was a good one. I wish I could ease your mind to give you some comfort prior to your November 8th consultation, but I believe it best to get diagnostic details from a physician who has access to all your medical information. I'm not a physician. I do think you are on the right path getting a second opinion, a tissue biopsy on the 2.6 cm nodule, and taking the liquid biopsy. 

Stay the course.

Tom

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.